Isothiazole derivatives as novel HIV replication inhibitors.
Cutrì
Christian C C
CC
Department of Pharmaceutical Sciences, University of Catania, Catania, Italy.
Garozzo
Adriana
A
Pannecouque
Christophe
C
Castro
Angelo
A
Guerrera
Francesco
F
De Clercq
Erik
E
D019380:Anti-HIV Agents / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D002460:Cell Line; D004220:Disulfides; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D015498:HIV-2 / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D015394:Molecular Structure; D013844:Thiazoles / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D014779:Virus Replication / Q000187:drug effects*
C525631:5-phenyl-3-(4-cyano-5-phenylisothiazol-3-yl)disulfanyl-4-isothiazolecarbonitrile; D019380:Anti-HIV Agents; D004220:Disulfides; C525632:S-(4-cyano-5-phenylisothiazol-3-yl)-O-ethyl thiocarbonate; D013844:Thiazoles